Halozyme (HALO) is up 11% to $50.99 in pre-market trading.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVO:
- Halozyme withdraws proposal to acquire Evotec
- Halozyme withdraws proposal to acquire Evotec for EUR 11.00 per share in cash
- Spirit enters into bankruptcy proceedings, CVS names new directors: Morning Buzz
- Halozyme provides update on proposal to combine with Evotec
- Berkshire reveals stake in Domino’s, Alibaba reports mixed Q2: Morning Buzz